Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference
Preclinical study shows Adicet’s Allogeneic Gamma Delta T Cell Platform may be a Promising Approach for Prostate Cancer ...
United States Nitya Ramadoss Dimeric Epitope European Organisation For Research Adicet Bio Inc National Cancer Institute
Source: marketscreener.com